FOXO3 and chronic myelogenous leukemia, BCR-ABL1 positive: In FoxO3a-deficient mice, serial transplantation of leukemia-initiating cells reduced the LSC population in the CML mouse model which was more notable by imatinib as a tyrosine kinase inhibitor.149